Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of Patients With Age-related Macular Degeneration - an Alternative to Supplements With Isolated Xanthophylls

NCT02136303 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.

NCT NCT02136303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02136303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of Patients With Age-related Macular Degeneration - an Alternative to Supplements With Isolated Xanthophylls
Lead sponsor
University of Jena
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2020
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

changes in macular pigment optical density